Generics - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

151 to 175 of 566 results

GlaxoSmithKline and A*STAR's ICES to develop medicines for emerging markets

09-04-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and Singapore-based A*STAR's Institute of Chemical and Engineering…

GenericsGlaxoSmithKlineGlobalPharmaceuticalResearch

Activists protest in front of the European Parliament to stop EU-India trade deal "harmful" provisions

09-04-2013

As European Commission pressure mounts on India to rush into signing a free trade agreement (FTA) by…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPoliticsPricing

CNS therapeutics market facing downward pressure as branded drugs continue to expire

08-04-2013

The global central nervous system (CNS) therapeutics market has been forecast to reach $133 billion by…

GenericsGlobalMarkets & MarketingNeurologicalPharmaceutical

Pilot project for HIV/AIDS drug management supported by PAHO/WHO and the Global Fund may expand to other countries

07-04-2013

Three Latin American countries - Guatemala, Honduras, and the Dominican Republic - are working to strengthen…

Anti-viralsGenericsHealthcareManagementPharmaceuticalSouth America

US-India Business Council has concerns over India's ruling on Novartis' Glivec

03-04-2013

This week's long awaited Supreme Court of India ruling, which denied a patent on Swiss drug major Novartis'…

Asia-PacificGenericsGlivecNovartisPatentsPharmaceutical

Merz Pharma enters bidding war for Obagi; Ferro sells pharma unit

02-04-2013

German family-owned firm Merz Pharma has written to the board of director of Obagi Medical Products outlining…

Ferro GroupGenericsMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPfanstiehl LaboratoriesPharmaceuticalValeant Pharmaceuticals

India's Supreme Court denies Novartis Glivec patent appeal

02-04-2013

In a landmark decision issued on Monday (April 1) by the Indian Supreme Court has denied Swiss drug major…

Asia-PacificGenericsGlivecLegalNovartisOncologyPatentsPharmaceutical

News briefs: Dr Reddy's launches generic Accutane; Cyprus drug shortages

29-03-2013

Indian drugmaker Dr Reddy's Laboratories (NYSE: RDY) says it launched Zenatane (isotretinoin capsules…

AccutaneDermatologicalsDr Reddy's LaboratoriesEuropeGenericsHealthcareMarkets & MarketingNorth AmericaPharmaceuticalZenatane

AstraZeneca in Crestor patent settlement with Actavis and EGIS Pharma

25-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered into a settlement agreement in its US patent…

ActavisCardio-vascularCrestorGenericsNorth AmericaPatentsPharmaceuticalrosuvastatinShionogiWatson Pharmaceuticals

For first time in 20 years, Australia's PBS spending in decline

22-03-2013

For the first time in 20 years government expenditure on the Pharmaceutical Benefits Scheme (PBS) in…

Asia-PacificFinancialGenericsHealthcarePharmaceuticalPricing

US lobby group pressures Greek government to introduce compulsory licensing of drugs

19-03-2013

USA-based not-for-profit lobby group Essential Inventions has written to Greek Health Minister Andreas…

EuropeGenericsHealthcarePatentsPharmaceuticalPricing

Generic medicines policies are driving significant savings in Australia, claims GMiA

18-03-2013

Australian taxpayers and patients alike benefit from having increased access to the more affordable generic…

Asia-PacificGenericsHealthcarePharmaceuticalPricing

Public Citizen slams FDA over lax oversight of "compounding pharmacies"

18-03-2013

Strengthened enforcement over compounding pharmacies that act as drug manufacturers would help alleviate…

GenericsNorth AmericaPharmaceuticalProductionRegulation

DNP+ and MSF urge India to reject EU demands on trade deal before April deadline

13-03-2013

Pressure is mounting on India to quickly sign off on a free trade agreement with the European Union which…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPolitics

EMA focuses on new legislation, increased efficiency and transparency in 2013 work program

13-03-2013

The European Medicines Agency has published its work program for 2013. This year, the Agency's priorities…

BiotechnologyEuropeGenericsPharmaceuticalRegulation

Hikma delivers revenue growth of 21% and EPS up 24% for 2012

13-03-2013

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported preliminary results for 2012, showing…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Experts to examine opportunities in growing African pharmaceutical market

12-03-2013

"At a time when growth in traditional pharmaceutical markets is stalling, strong macroeconomic fundamentals…

GenericsMarkets & MarketingPharmaceuticalRegulationRest of the World

Indian Pharma growth outpaces rivals, but must embrace innovation

12-03-2013

Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

Thailand flouts pharmaceutical patent protection; report

08-03-2013

Lax enforcement of patent regulations in Thailand is alienating American intellectual property laws,…

Asia-PacificGenericsMarkets & MarketingPatentsPharmaceutical

Further savings expected following Australian Crestor patent decision, says GMiA

07-03-2013

In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…

Asia-PacificAstraZenecaCardio-vascularCrestorGenericsPatentsPharmaceuticalPricing

Par Pharma agrees $45 million settlement over off-label Megace ES promotion

07-03-2013

US generic drugmaker Par Pharmaceutical NYSE: PRX) pleaded guilty in federal court yesterday (March 6)…

FinancialGenericsLegalMarkets & MarketingMegace ESMetabolicsNorth AmericaPar PharmaceuticalPharmaceutical

151 to 175 of 566 results

Back to top